Nuvation Bio Positioned for Growth: Buy Rating Affirmed on Strategic Moves and Promising Drug Pipeline
PremiumRatingsNuvation Bio Positioned for Growth: Buy Rating Affirmed on Strategic Moves and Promising Drug Pipeline
28d ago
Nuvation Bio files automatic mixed securities shelf
Premium
The Fly
Nuvation Bio files automatic mixed securities shelf
28d ago
Nuvation Bio reports Q4 EPS (15c), two estimates (12c)
Premium
The Fly
Nuvation Bio reports Q4 EPS (15c), two estimates (12c)
28d ago
Nuvation Bio price target raised to $11 from $10 at H.C. Wainwright
PremiumThe FlyNuvation Bio price target raised to $11 from $10 at H.C. Wainwright
2M ago
Nuvation Bio price target raised to $10 from $6 at RBC Capital
Premium
The Fly
Nuvation Bio price target raised to $10 from $6 at RBC Capital
3M ago
Nuvation gets China NMPA approval for taletrectinib for ROS1-positive NSCLC
Premium
The Fly
Nuvation gets China NMPA approval for taletrectinib for ROS1-positive NSCLC
3M ago
Nuvation Bio Announces Philippe Sauvage as New CFO
PremiumCompany AnnouncementsNuvation Bio Announces Philippe Sauvage as New CFO
6M ago
Nuvation Bio names Philippe Sauvage CFO
Premium
The Fly
Nuvation Bio names Philippe Sauvage CFO
6M ago
Navigating Legal Uncertainty: Nuvation Bio Inc.’s Chinese Operations and the Shifting Landscape of China’s Civil Law System
Premium
Company Announcements
Navigating Legal Uncertainty: Nuvation Bio Inc.’s Chinese Operations and the Shifting Landscape of China’s Civil Law System
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100